Showing results (21-30 of 1,282) with videos related to
Sort By:
Pageof 129
Lancet (London, England)|May 26, 2009
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trialsKausik K Ray, Sreenivasa Rao Kondapally Seshasai, Shanelle Wijesuriya, et al.Atherosclerosis|October 10, 2014
The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspectiveNaomi J Rankin, David Preiss, Paul Welsh, et al.The Lancet. Diabetes & Endocrinology|February 13, 2016
Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient dataNaveed Sattar, David Preiss, Jennifer G Robinson, et al.Diabetes|October 27, 2004
Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention studyNaveed Sattar, Olga Scherbakova, Ian Ford, et al.Clinical Science (London, England : 1979)|October 11, 2008
More knocks to the oxidation hypothesis for vascular disease?Adam Mullan, Naveed SattarCurrent Opinion in Lipidology|June 11, 2009
Triglycerides and coronary heart disease: have recent insights yielded conclusive answers?Nadeem Sarwar, Naveed SattarThe Journal of Investigative Dermatology|September 25, 2021
Estimating Cardiovascular Impacts of Drugs for Psoriatic Disease: A Long Way to GoStefan Siebert, Naveed SattarCurrent Cardiology Reports|November 24, 2019
Management of Lipid Abnormalities in Patients with DiabetesAnne Sillars, Naveed SattarCurrent Obesity Reports|August 10, 2021
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health CareNaveed Sattar, Jonathan ValabhjiPageof 129